Consistent with previous findings, LUAD patients with a low DS demonstrated a high level of immune cell infiltration, including CD8 cells, NK cells, B cells, dendritic cells, mast cells, and central memory T cells, all of which play crucial roles in either bolster or counter tumor immunity during immunotherapy. The gene discussed is CD8A; the disease is neoplasm.